BCM
GMED icon

Bayesian Capital Management’s Globus Medical GMED Stock Holding History

Bayesian Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,028
Closed -$892K – 816
2024
Q2 		$892K Buy
13,028
+5,500
+73% +$329K 0.1% 255
2024
Q1 		$404K Buy
+7,528
New +$405K 0.04% 483
2023
Q4 		– Sell
-13,191
Closed -$655K – 860
2023
Q3 		$655K Buy
+13,191
New +$738K 0.07% 307
2023
Q2 		– Sell
-4,060
Closed -$230K – 897
2023
Q1 		$230K Buy
+4,060
New +$260K 0.03% 575
2022
Q4 		– Sell
-4,700
Closed -$280K – 864
2022
Q3 		$280K Buy
+4,700
New +$283K 0.06% 435
2022
Q1 		– Sell
-5,500
Closed -$397K – 824
2021
Q4 		$397K Buy
+5,500
New +$399K 0.13% 215
2021
Q2 		– Sell
-6,627
Closed -$409K – 494
2021
Q1 		$409K Buy
6,627
+3,459
+109% +$219K 0.09% 272
2020
Q4 		$207K Sell
3,168
-4,570
-59% -$263K 0.05% 376
2020
Q3 		$383K Buy
+7,738
New +$399K 0.09% 293
2018
Q4 		– Sell
-10,554
Closed -$599K – 671
2018
Q3 		$599K Sell
10,554
-300
-3% -$15.8K 0.1% 289
2018
Q2 		$548K Buy
+10,854
New +$566K 0.12% 245
2018
Q1 		– Sell
-16,412
Closed -$675K – 675
2017
Q4 		$675K Buy
+16,412
New +$575K 0.14% 250
2017
Q3 		– Sell
-10,300
Closed -$341K – 536
2017
Q2 		$341K Buy
+10,300
New +$324K 0.13% 253
2016
Q1 		– Sell
-7,972
Closed -$222K – 384
2015
Q4 		$222K Buy
+7,972
New +$200K 0.32% 155

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Bayesian Capital Management's GMED Position: Q3 2024 in Review

Bayesian Capital Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 13,028 shares — an estimated $892K sold.

Bayesian Capital Management first reported a position in GMED in Q4 2015 and held it in 14 quarters. The position peaked at $892K in Q2 2024. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Bayesian Capital Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 13,028 Globus Medical shares in Q3 2024, an estimated $892K.
  • Bayesian Capital Management first reported a position in Globus Medical in Q4 2015 and held it in 14 quarters.
  • Bayesian Capital Management's Globus Medical position peaked at $892K in Q2 2024.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.